OLIF | TLIF | P | |
---|---|---|---|
Age (years) | 73.13 ± 6.85 | 72.02 ± 6.47 | 0.204 |
Male/Female | 12/48 | 15/45 | 0.512 |
BMI (kg/m2) | 24.36 ± 3.57 | 24.83 ± 3.35 | 0.456 |
ASA | 2.40 ± 0.53 | 2.63 ± 0.89 | 0.169 |
≤ 2 | 36(60.0%) | 33 (55.0%) | |
2 < n ≤ 4 | 24(40.0%) | 27(45.0%) | |
CCI | 4.80 ± 1.46 | 4.73 ± 1.29 | 0.766 |
n ≤ 2 | 36(60.0%) | 32(53.3%) | |
> 2 | 24(40.0%) | 28(46.7%) | |
Hemoglobin (g/L) | 127.21 ± 15.04 | 126.48 ± 13.89 | 0.491 |
Albumin (g/L) | 38.74 ± 3.61 | 38.28 ± 3.49 | 0.297 |
Total lymphocyte counts(109/L) | 1.77 ± 0.78 | 1.92 ± 0.73 | 0.631 |
Co-Morbidities, n (%) | |||
Osteoporosis | 31(51.6%) | 37(61.6%) | |
Diabetes disease | 9(15.0%) | 18(30.0%) | |
Hypertension | 25(41.6%) | 43(71.6%) | |
Schizas Grade | 2.85 ± 0.92 | 2.98 ± 0.98 | |
Grade A | 6(10.0%) | 8(13.3%) | 0.471 |
Grade B | 15(25.0%) | 10(16.7%) | |
Grade C | 25(41.7%) | 24(40.0%) | |
Grade D | 14(23.3%) | 18(30.0%) | |
Lee Grade | 0.432 | ||
Grade 0/1 | 7(11.7%) | 10(16.7%) | |
Grade 2/3 | 53(88.3%) | 50(83.3%) | |
Operative time (min) | 106.25 ± 34.92 | 120.88 ± 38.06 | 0.218 |
Estimated blood loss (ml) | 166.13 ± 85.52 | 239.42 ± 103.83 | 0.061 |